Kisspeptin-10 30mg — Vial Spec, Reconstitution Math & COA

Overview of Kisspeptin-10 30mg Vial Specifications

A 30mg vial of Kisspeptin-10 contains thirty milligrams of lyophilized decapeptide (sequence: YNWNSFGLRF-NH2, MW: 1302.45 g/mol) prepared as a high-purity trifluoroacetate or acetate salt. This bulk packaging format is primarily specified by institutional laboratories conducting high-frequency receptor kinetic assays, long-term non-human animal tissue microperfusion models, or automated high-content screening. Because of the expanded peptide mass relative to standard analytical aliquots, the 30mg format minimizes inter-vial batch variation across multi-well assays.

PX1 Research maintains rigorous quality control standards across all catalog mass configurations. While standard individual assays frequently utilize our core Kisspeptin-10 product line, high-throughput laboratories often require higher-yield vials to prepare uniform stock master mixes. Researchers should note that PX1 Research provides custom and large-format fills upon request; if a specific 30mg SKU is temporarily unlisted on the primary catalog, standard 10mg unit multiples are supplied with identical batch-matched purity metrics to preserve experimental continuity across all research peptides.

Molecular Structure and Upstream HPG Axis Mechanics

Kisspeptin-10 represents the minimal active C-terminal sequence derived from the primary precursor product of the *KISS1* gene. In preclinical model systems, it functions as an endogenous agonist for the G-protein coupled receptor GPR54 (also designated as the KISS1R receptor). Binding of Kisspeptin-10 to GPR54 initiates a Gαq/11-coupled intracellular cascade, activating phospholipase C (PLC), inducing intracellular calcium mobilization, and driving protein kinase C (PKC) phosphorylation pathways within targeted neuronal populations.

The primary locus of Kisspeptin-10 activity resides in the arcuate nucleus and anteroventral periventricular nucleus (AVPV) of the hypothalamus. Preclinical studies suggest that Kisspeptin-10 acts as the direct upstream neuroendocrine accelerator for gonadotropin-releasing hormone (GnRH) release. By depolarizing GnRH-expressing neurons, Kisspeptin-10 stimulates downstream pituitary secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Consequently, it serves as a critical molecular tool for interrogating central reproductive regulation, feedback sensitivity, and central pubertal timing mechanisms in vitro and in rodent tissue models.

Comparative Analysis: Kisspeptin-10 vs. Alternative HPG Axis Modulators

When designing neuroendocrine assays, investigators frequently evaluate Kisspeptin-10 against direct pituitary regulators and synthetic decapeptides. Unlike direct GnRH receptor agonists, Kisspeptin-10 acts at the hypothalamic level, preserving natural endogenous feedback control mechanisms in intact tissue models.

In comparative preclinical models, compounds such as Triptorelin and Gonadorelin bind directly to anterior pituitary GnRH receptors, triggering immediate downstream LH/FSH secretion followed by receptor desensitization upon sustained exposure. Conversely, Kisspeptin-10 acts upstream of GnRH secretion, enabling researchers to isolate hypothalamic input from pituitary responsiveness. Additionally, synthetic analogs within the broader GnRH class lack the precise GPR54 selectivity profile characteristic of Kisspeptin-10, making Kisspeptin-10 uniquely suited for studying central neuroendocrine drive without directly downregulating hypophyseal receptors.

Reconstitution Mathematics & Concentration Matrices for 30mg Fills

Accurate reconstitution of high-mass peptide vials requires precise volumetric calculation to achieve target working stock concentrations. To avoid peptide precipitation or miscalculated dosing in microplate wells, diluent volume must be measured using calibrated analytical pipettes. For precise automated conversion values across variable concentrations, investigators may utilize the PX1 reconstitution calculator.

The table below details final working stock concentrations for a standard 30mg Kisspeptin-10 vial across typical solvent volumes:

• 1.0 mL Diluent Volume: Yields a stock concentration of 30.0 mg/mL (30,000 µg/mL; ~23.03 mM). • 2.0 mL Diluent Volume: Yields a stock concentration of 15.0 mg/mL (15,000 µg/mL; ~11.52 mM). • 3.0 mL Diluent Volume: Yields a stock concentration of 10.0 mg/mL (10,000 µg/mL; ~7.68 mM). • 6.0 mL Diluent Volume: Yields a stock concentration of 5.0 mg/mL (5,000 µg/mL; ~3.84 mM).

When performing serial dilutions for cell culture assays (e.g., targeting nanomolar working ranges from 1 nM to 100 nM), primary master stocks should be prepared at 1.0 mg/mL using sterile 0.9% sodium chloride or bacteriostatic water, followed by step-down dilutions in secondary assay buffers.

Aliquot Planning & Stability Protocols for High-Mass Vials

Because repeated freeze-thaw cycles induce peptide degradation through mechanical shear forces and hydrophobic aggregation, 30mg vials should never be repeatedly thawed after initial solution preparation. Upon reconstitution, the master solution must be immediately sub-aliquoted into single-use polypropylene low-binding microcentrifuge tubes.

Aliquot size should be calculated based on daily assay throughput (e.g., 50 µL to 200 µL working volumes). Aliquots intended for use within 48 to 72 hours may be maintained at 2°C to 8°C. For long-term storage of reconstituted stock, aliquots must be flash-frozen and stored at -20°C or -80°C. Sterile, preservative-free solutions should be utilized immediately in cell culture environments to eliminate cytotoxic artifacts associated with benzyl alcohol.

Analytical Verification: HPLC, MS, and Endotoxin Testing

Every production lot of Kisspeptin-10 manufactured for PX1 Research undergoes multi-point analytical verification at an independent, ISO 17025-accredited testing facility. Chemical identity is established via Electrospray Ionization Mass Spectrometry (ESI-MS), verifying that the observed molecular weight corresponds to the theoretical mass of 1302.45 Da within target resolution limits.

Purity is quantitatively determined via High-Performance Liquid Chromatography (HPLC) using a reversed-phase C18 column under a gradient trifluoroacetic acid/acetonitrile mobile phase. PX1 Research enforces a strict baseline specification of ≥98.0% chromatographic purity for all lots. Furthermore, because cell culture models are highly sensitive to bacterial contaminants, every batch undergoes Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below <0.05 EU/mg. Access to batch-matched documentation is public via our COA lookup hub.

Choosing the Optimal Format: 30mg vs. Standard 10mg Vials

Selecting between a high-mass 30mg vial format and standard 10mg research vials depends on experimental scale, assay frequency, and solvent usage constraints. High-throughput facilities running screening libraries or continuous perfusion setups benefit from the administrative efficiency and unified lot integrity of 30mg fills.

Conversely, laboratories performing periodic, low-volume pilot studies may find 10mg vials more practical. Utilizing smaller mass fills reduces the risk of long-term storage degradation for reconstituted solutions that remain unused after unsealing. Both packaging configurations originate from identical synthesis runs in GMP-compliant facilities, ensuring identical chemical characteristics Regardless of container mass.

Preclinical Assay Design and In Vitro Applications

In preclinical research frameworks, Kisspeptin-10 is widely deployed to investigate neuroendocrine signal transduction. Common experimental methodologies include:

• Hypothalamic Explant Perfusion: Measuring dynamic GnRH release rates into culture media following pulse administration of Kisspeptin-10. • Pituitary Cell Co-Culture: Analyzing differential LH/FSH secretion profiles to delineate direct versus indirect neuroendocrine feedback loops. • Fluorometric Calcium Imaging: Quantifying intracellular Ca2+ flux in GT1-7 or GnRH-expressing neuronal cell lines to assess GPR54 agonist efficacy. • Gene Expression Profiling: Evaluating changes in *Fshb*, *Lhb*, and *Gnrhr* transcript levels via quantitative RT-PCR following exposure to Kisspeptin-10.

Data derived from these in vitro assays consistently highlight the potency of Kisspeptin-10 as a tool for uncoupling upstream central neuroendocrine signaling from terminal gonadal steroid feedforward pathways.

Procurement, Compliance, and Bulk Lab Fulfillment

PX1 Research supplies high-purity research compounds strictly intended for laboratory-based in vitro and preclinical research applications. All products are manufactured in modern, GMP-compliant facilities within the United States and ship directly from our distribution centers in California and Arizona. Orders placed Monday through Friday before cut-off times qualify for same-day dispatch.

Institutional buyers managing large-scale screening operations or regional research consortiums can access expanded volume pricing, dedicated batch reservation, and custom vial sizing through our wholesale program. Detailed mechanistic overviews and compound cross-references are available within the PX1 research library.